The Oncology Institute, Inc. TOI Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, number?
- The Oncology Institute, Inc. (TOI) reported share-based compensation arrangement by share-based payment award, options, outstanding, number of $3.93M in Q1 2026.
- How has The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, number changed year-over-year?
- The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, number decreased by 44.8% year-over-year, from $7.12M to $3.93M.
- What is the long-term trend for The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, number?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, number has grown at a -12.7% compound annual growth rate (CAGR), from $6.92M to $4.02M.